Researchers from the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation’s top 50 best hospitals for cancer, presented results from 31 major studies of blood-related cancers – leukemia, lymphoma and multiple myeloma — during the American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011 in San Diego. Research highlights ...
Lymphomas and leukemias of the nervous system result in devastating neurological complications and high mortality. These malignancies may arise within the central nervous system or may disseminate to the brain or cerebrospinal fluid from a source elsewhere in the body. Early diagnosis and therapeutic intervention lead to improvement in neurological symptoms and signs and potentially ...
Decoding the DNA of a woman who died of acute myeloid leukemia (AML) has led researchers at Washington University School of Medicine in St. Louis to a gene that they found to be commonly altered in many patients who died quickly of the disease. The findings, if confirmed in larger studies, suggest that a diagnostic ...
Bristol-Myers Squibb today announced that SPRYCEL (dasatinib) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive Chronic Myelogenous Leukaemia in Chronic Phase (CML-CP). This decision follows the presentation of results from the pivotal DASISION study in which dasatinib ...
The U.S. House of Representatives passed House Resolution 1433, declaring September 2010 as ‘Blood Cancer Awareness Month.’ The resolution helps raise awareness and support for issues affecting blood cancer patients within the halls of the Capitol. “Awareness Month is an opportunity to increase the public’s understanding of blood cancers and encourage people to support the ...
